The Underdog Increasing Presence & Innovation with the Government…DARPA….

Advancing & enhancing nanotechnology cellular “theranostic” performance for disease targeting methods.

Lawrence, MA, May 30, 2017– Today we’re proud to announce the initial footsteps and confirmation of initiating a contract over the next few months with DARPA. Defense Advanced Research Projects Agency (DARPA), is an agency within the Department of Defense (DoD) that is responsible for advanced research projects, and being able to transform the research into ground-breaking technologies for mission critical products. Rubix Strategies will be working on a specific project, that will leverage its neurodegenerative platform, that will transform the pipeline project as a therapeutic diagnostic, or theranostic, to predictively ascertain critical cellular data for combating advance neurotoxins.

“This is a complete validation that some of the projects we’re working on, is not just stardust, but has now piqued the interests of some advanced minds of federal research agencies like DARPA” – Reginald Swift, CEO

With this announcement, we believe the intellectual capital will now begin to grow as this will directly be correlated to expanding our team by hiring locally in the city. This message is loud and clear, we’re establishing a biotech R&D cluster in a gateway city like Lawrence.

At Rubix Strategies, we strive to continue advancement of combination technologies that will do as our company slogan; “Bringing Tomorrow. Today”

If you would like more information about this topic, please contact Rubix Strategies at 978-655-6770 or email at info@rubixinc.us.

Rubix Strategies, LLC

60 Island St.

Lawrence, MA 01840

Phone: 978-655-6770

https://rubixinc.us

Contact:

Reginald Swift

CEO

email: rswift@rubixinc.us

All Topics